Literature DB >> 15802067

Gallbladder pathology in morbid obesity.

George W Dittrick1, Jon S Thompson, Daniel Campos, Doug Bremers, Debra Sudan.   

Abstract

BACKGROUND: Obese patients are at increased risk for biliary disease. The prevalence and type of gallbladder pathology in morbidly obese patients was evaluated, and compared with a non-obese control group.
METHODS: A consecutive series of obese patients (n=478) who had undergone bariatric surgery with concurrent routine cholecystectomy and a consecutive group of organ donors (n=481) were compared. Gallbladder pathology was defined as: cholelithiasis, cholecystitis, cholesterolosis, or normal pathology.
RESULTS: Mean age of obese patients and of donors was 42 +/- 9 and 43 +/- 17 years respectively and mean BMI was 52 +/- 10 and 27 +/- 7 kg/m2 respectively, P<0.05. There were more females in the obesity group (88% vs 47%, P<0.0001). 31% of obese patients and 7% of controls had a previous cholecystectomy (P<0.0001). 21% of the obese and 72% of the controls had normal gallbladder pathology (P<0.0001). Overall, obese patients had a higher incidence of cholelithiasis (25% vs 5%, P<0.0001), cholecystitis (50% vs 17%, P<0.0001), and cholesterolosis (38% vs 6%, P<0.0001) compared with controls. Obese patients with BMI <50 were more likely than those with BMI > or =50 to have normal gallbladder pathology (27% vs 14%, P<0.001). Female patients were more likely to have undergone previous cholecystectomy than males in both the obese group (34% vs 11%, P<0.001) and the control group (12% vs 2%, P<0.0001). Normal pathology was more common in male patients (80% vs 63%, P<0.0001) and patients <50 years (76% vs 66%, P<0.05) in the control group.
CONCLUSIONS: Obese patients have an increased incidence of benign gallbladder disease than a group of controls, and the relative risk appears to be positively correlated with the level of increase in the BMI. Obesity appears to change the effect of age and gender on gallbladder pathology.

Entities:  

Mesh:

Year:  2005        PMID: 15802067     DOI: 10.1381/0960892053268273

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  32 in total

1.  Effect of genetic variants related to lipid metabolism as risk factors for cholelithiasis after bariatric surgery in Brazilian population.

Authors:  Sidney Pinheiro-Júnior; Marcela A S Pinhel; Marcelo A Nakazone; Anielli Pinheiro; Gisele F S Amorim; Greiciane M S Florim; Camila M Mazeti; Michele L Gregório; Marina G Moschetta; Gilberto B Brito; Sérgio L A Brienze; Carla B Nonino; Antonio C Brandão; Dorotéia R S Souza
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

2.  Hepatic evisceration after cholecystectomy in a super obese patient.

Authors:  José Ignacio Rodríguez-Hermosa; Bartomeu Ruiz-Feliú; Josep Roig-García; Jordi Gironès-Vilà; Pere Planellas-Giné; Pedro Ortuño-Muro; Antoni Codina-Cazador
Journal:  Obes Surg       Date:  2008-01-05       Impact factor: 4.129

3.  Prevalence of Cholelithiasis and Choledocholithiasis in Morbidly Obese South Indian Patients and the Further Development of Biliary Calculus Disease After Sleeve Gastrectomy, Gastric Bypass and Mini Gastric Bypass.

Authors:  Tapas Mishra; Kona Kumari Lakshmi; Kiran Kumar Peddi
Journal:  Obes Surg       Date:  2016-10       Impact factor: 4.129

Review 4.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

5.  The evaluation of gallstone formation in patients undergoing Roux-en-Y gastric bypass due to morbid obesity.

Authors:  Metin Karadeniz; Mehmet Görgün; Cemal Kara
Journal:  Ulus Cerrahi Derg       Date:  2014-06-01

6.  Hepatic evisceration after cholecystectomy in a superobese patient.

Authors:  José Ignacio Rodríguez-Hermosa; Bartomeu Ruiz-Feliú; Josep Roig-García; Jordi Gironès-Vilà; Pere Planellas-Giné; Pedro Ortuño-Muro; Antoni Codina-Cazador
Journal:  Obes Surg       Date:  2008-05-28       Impact factor: 4.129

7.  Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass?

Authors:  Mathieu D'Hondt; Gregory Sergeant; Bert Deylgat; Dirk Devriendt; Frank Van Rooy; Franky Vansteenkiste
Journal:  J Gastrointest Surg       Date:  2011-07-13       Impact factor: 3.452

8.  Concomitant cholecystectomy during laparoscopic sleeve gastrectomy.

Authors:  Asnat Raziel; Nasser Sakran; Amir Szold; David Goitein
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

9.  Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.

Authors:  Phui-Ly Liew; Wei-Jei Lee; Weu Wang; Yi-Chih Lee; Wei-Yu Chen; Chia-Lang Fang; Ming-Te Huang
Journal:  Obes Surg       Date:  2008-05-06       Impact factor: 4.129

10.  Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery?

Authors:  O N Tucker; P Fajnwaks; S Szomstein; R J Rosenthal
Journal:  Surg Endosc       Date:  2008-02-21       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.